Publicaciones en las que colabora con BEATRIZ GARCÍA PAREDES (14)

2023

  1. Association of Circulating Tumor Cells and Tumor Molecular Profile With Clinical Outcomes in Patients With Previously Untreated Metastatic Colorectal Cancer: A Pooled Analysis of the Phase III VISNÚ-1 and Phase II VISNÚ-2 Randomized Trials

    Clinical Colorectal Cancer, Vol. 22, Núm. 2, pp. 222-230

2021

  1. First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled Analysis

    Drugs and Aging, Vol. 38, Núm. 3, pp. 219-231

  2. Influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab or cetuximab as first-line therapy in patients with RAS wild-type metastatic colorectal carcinoma and <3 baseline circulating tumour cells: the randomised phase II VISNÚ-2 study

    ESMO open, Vol. 6, Núm. 2, pp. 100062

2017

  1. Role of GALNT12 in the genetic predisposition to attenuated adenomatous polyposis syndrome

    PLoS ONE, Vol. 12, Núm. 11

2016

  1. Risk-adapted adjuvant chemotherapy after concomitant fluoropyrimidine-radiotherapy neoadjuvant treatment for patients with resectable CT3-4 or N+ rectal cancer: Five-year disease-free survival results of a single-center series

    Clinical Colorectal Cancer, Vol. 15, Núm. 2, pp. 128-134

2015

  1. BRCA2 gene: A candidate for clinical testing in familial colorectal cancer type X

    Clinical Genetics, Vol. 87, Núm. 6, pp. 582-587

  2. «Regime farmacologico FOLFIRI come trattamento di seconda linea per il cancro gastric metastatico: Analisi retrospettiva della efficacia, della sicurezza e dei fattori prognostici»

    European Journal of Oncology, Vol. 20, Núm. 1, pp. 32-40

2014

  1. Role of cetuximab in first-line treatment of metastatic colorectal cancer

    World Journal of Gastroenterology, Vol. 20, Núm. 15, pp. 4208-4219

  2. Should capecitabine replace 5-fluorouracil in the first-line treatment of metastatic colorectal cancer?

    World Journal of Gastroenterology, Vol. 20, Núm. 20, pp. 6092-6101

2011

  1. Circulating tumor cells: Clinical applicability

    Cancer and Chemotherapy Reviews, Vol. 6, Núm. 1, pp. 3-11

  2. Células tumorales circulantes en cáncer colorrectal

    Revisiones en Cancer, Vol. 25, Núm. 3, pp. 142-148

2007

  1. Osteonecrosis of the jaw as an adverse bisphosphonate event: Three cases of bone metastatic prostate cancer patients treated with zoledronic acid

    Medicina oral, patología oral y cirugía bucal. Ed. inglesa, Vol. 12, Núm. 5, pp. 4

2006

  1. Cáncer de pulmón

    Tiempos médicos: revista de educación médica continuada, Núm. 631, pp. 11-22

  2. Cáncer de pulmón no microcítico: quimioterapia y otros tratamientos sistémicos

    Psicooncología: investigación y clínica biopsicosocial en oncología, Vol. 3, Núm. 2, pp. 229-248